Provided by Tiger Fintech (Singapore) Pte. Ltd.

Edwards Lifesciences

75.04
+0.12000.16%
Post-market: 75.090.0500+0.07%17:30 EDT
Volume:2.42M
Turnover:181.81M
Market Cap:43.96B
PE:10.68
High:75.75
Open:74.83
Low:74.41
Close:74.92
Loading ...
Oct 28, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 27, 2022

Major Issues Report

8-K - Current report
Oct 07, 2022

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Jul 29, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 28, 2022

Major Issues Report

8-K - Current report
Jul 21, 2022

Major Issues Report

8-K - Current report
Jun 16, 2022

Employee Stock Ownership

11-K - Annual report of employee stock purchase, savings and similar plans
Jun 16, 2022

Employee Stock Ownership

11-K - Annual report of employee stock purchase, savings and similar plans
May 04, 2022

Major Issues Report

8-K - Current report
Apr 28, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 26, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 26, 2022

Major Issues Report

8-K - Current report
Nov 29, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 24, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 10, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 09, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 08, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities